References
- Freire M, Neto MS, Garcia EB, et al. Quality of life after reduction mammaplasty. Scand J Plast Reconstr Surg Hand Surg 2004;38:335–9.
- Saariniemi KMM, Keranen UH, Salminen-Peltola PK, Kuokkanen OM. Reduction mammaplasty is effective treatment according to two quality of life instruments. A prospective randomized clinical trial. J Plast Reconstr Aesth Surg 2008;61:1472–8.
- Colwell AS, Kukreja J, Breuing KH, et al. Occult breast carcinoma in reduction mammaplasty specimens: 14-year experience. Plast Reconstr Surg 2004;113:1984–8.
- Pitanguy I, Torres E, Salgado F, Pires Viana GA. Breast pathology and reduction mammaplasty. Plast Reconstr Surg 2005;115:729–34.
- Hartmann LC, Sellers TA, Frost MH, et al. Benign breast disease and the risk of breast cancer. N Engl J Med 2005;353:229–37.
- Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 1985;312:146–51.
- Page DL, Dupont WD, Rogers LW, Rados MS. Atypical hyperplastic lesions of the female breast. A long-term follow-up study. Cancer 1985;55:2698–708.
- Ishag MT, Bashinsky DY, Beliaeva IV, et al. Pathologic findings in reduction mammaplasty specimens. Am J Clin Pathol 2003;120:377–80.
- Kakagia D, Fragia K, Grekou A, Tsoutsos D. Reduction mammaplasty specimens and occult breast carcinomas. Eur J Surg Oncol 2005;31:19–21.
- Karabela-Bouropoulou V, Liapi-Avgeri G, Iliopoulou E, Agnantis NJ. Histological findings in breast tissue specimens from reduction mammaplasties. Pathol Res Pract 1994;190:792–8.
- Blansfield JA, Kukora JS, Goldhahn RT, Buinewicz BR. Suspicious findings in reduction mammaplasty specimens: review of 182 consecutive patients. Ann Plast Surg 2004;52:126–30.
- Ayhan S, Basterzi Y, Yavuzer R, et al. Histologic profiles of breast reduction specimens. Aesth Plast Surg 2002;26:203–5.
- Freedman BC, Rosenbaum Smith SM, Estabrook A, Balderacchi J, Tartter PI. Incidence of occult carcinoma and high-risk lesions in mammaplasty specimens. Int J Breast Cancer 2012;2012:ID145630.
- Clark CJ, Whang S, Paige KT. Incidence of precancerous lesions in breast reduction tissue: a pathologic review of 562 consecutive patients. Plast Reconstr Surg 2009;124:1033–9.
- Ambaye AB, MacLennan SE, Goodwin AJ, et al. Carcinoma and atypical hyperplasia in reduction mammaplasty: increased sampling leads to increased detection. A prospective study. Plast Reconstr Surg 2009;124:1386–92.
- Nielsen M, Jensen J, Andersen J. Precancerous and cancerous breast lesions during lifetime and at autopsy: a study of 83 women. Cancer 1984;54:612–15.
- Viana GA, Pitanguy I, Torres E. Histopathological findings in surgical specimens obtained from reduction mammaplasties. Breast 2005;14:242–8.
- Guray M, Sahin AA. Benign breast diseases: classification, diagnosis, and management. Oncologist 2006;11:435–49.
- Baasch M, Nielsen SF, Engholm G, Lund K. Breast cancer incidence subsequent to surgical reduction of the female breast. Br J Cancer 1996;73:961–3.
- Brown MH, Weinberg M, Chong N, et al. A cohort study of breast cancer risk in breast reduction patients. Plast Reconstr Surg 1999;103:1674–81.
- Hennedige AA, Kong TY, Gandh A. Oncological screening for bilateral breast reduction: a survey of practice variations in UK Breast and Plastics surgeons 2009. J Plast Reconst Aesth Surg 2011;64:878–83.
- Slezak S, Bluebond-Langner R. Occult carcinoma in 866 reduction mammaplasties: preserving the choice of Lumpectomy. Plast Reconstr Surg 2011;127:525–30.
- Keleher AJ, Langstein HN, Ames FC, et al. Breast cancer in reduction mammaplasty specimens: case reports and guidelines. Breast J 2003;9:120–5.
- Koltz PF, Girotto JA. The price of pathology: is screening all breast reduction specimens cost effective? Plast Reconstr Surg 2010;125:1575–6.
- Hassan FE, Pacifico MD. Should we be analyzing breast reduction specimens. A systematic analysis of over 1,000 consecutive cases. Aesthetic Plast Surg 2012;36:1105–13.